This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Analysis of 101 Cases at Autopsy

Peter Zbären, MD; Willy Lehmann, MD

Arch Otolaryngol Head Neck Surg. 1987;113(7):762-764.

Abstract
• One hundred one cases of squamous cell carcinoma of the upper respiratory and digestive tracts were analyzed for distant metastases. In all cases, autopsies were performed. Forty (40%) of the 101 patients had presented with one or more distant metastases. The most common sites of distant metastases were the lungs (70%), the liver (42%), and the bones (15%). There was a correlation between initial cervical lymph node involvement and development of distant metastases. In five cases of distant metastases, no tumor was found in the site of the primary lesion or in the cervical lymph nodes.

(Arch Otolaryngol Head Neck Surg 1987;113:762-764)

Author Affiliations
From the Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital, Geneva.

Footnotes
Accepted for publication Jan 15, 1987.

Reprint requests to Clinic of Otorhinolaryngology and Head and Neck Surgery, University Hospital, Geneva, Switzerland (Dr Zbären).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus.
Tijink et al.
Clin. Cancer Res. 2006;12:6064-6072.
ABSTRACT | FULL TEXT  

Risk factors for distant metastases in head and neck squamous cell carcinoma.
Garavello et al.
Arch Otolaryngol Head Neck Surg 2006;132:762-766.
ABSTRACT | FULL TEXT  

The Expanding Role of Systemic Therapy in Head and Neck Cancer
Cohen et al.
JCO 2004;22:1743-1752.
ABSTRACT | FULL TEXT  

Phase I Therapy Study with 186Re-labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab) in Patients with Head and Neck Squamous Cell Carcinoma
Borjesson et al.
Clin. Cancer Res. 2003;9:3961s-3972s.
ABSTRACT | FULL TEXT  

Analysis of Risk Factors Predictive of Distant Failure After Targeted Chemoradiation for Advanced Head and Neck Cancer
Doweck et al.
Arch Otolaryngol Head Neck Surg 2001;127:1315-1318.
ABSTRACT | FULL TEXT  

T3 Glottic Carcinoma Revisited: Transglottic vs Pure Glottic Carcinoma
Hao et al.
Arch Otolaryngol Head Neck Surg 1995;121:166-170.
ABSTRACT  

Analyses of Distant Metastases in Squamous Cell Carcinoma of the Head and Neck and Lesions Above the Clavicle at Autopsy
Nishijima et al.
Arch Otolaryngol Head Neck Surg 1993;119:65-68.
ABSTRACT